Evaluation of the effect of formulation Arctium Lappa in the treatment of Mild-to-moderate Acne

Phase 3

• Conditions: ?Acne Vulgaris.; Acne vulgaris (or simply acne) is a long-term skin disease that occurs when hair follicles become clogged with dead skin cells and oil from the skin. Acne is characterized by areas of blackheads, whiteheads, pimples, and greasy skin, and may result in sca; L70.0

• Registration Number: IRCT20191111045408N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Women and men aged 12-30 years with mild to moderate acne vulgaris
Have signed the informed consent form

Exclusion Criteria

Pregnant or breastfeeding or planning to become pregnant
Have a history of sensitivity to the components of the formulations used in the study
Other skin diseases such as eczema that make it difficult to evaluate the response to treatment
Have uncontrolled systemic disease
They have Acne Conglobata
Not taking the following drugs before starting the plan (topical anti-acne drugs for two weeks, oral antibiotics for one month, 12 weeks hormone therapy and 6 months oral retinoids).

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acne Complication. Timepoint: One month after intervention, two months after intervention, three months after intervention. Method of measurement: Based on acne lesion counting.